Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from TOT BIOPHARM International Co. Ltd. ( (HK:1875) ) is now available.
BioDlink International Company Limited has announced that its board of directors will convene on August 12, 2025, to review and approve the interim financial results for the first half of the year ending June 30, 2025. This meeting is crucial for stakeholders as it will provide insights into the company’s financial health and operational performance, potentially impacting its market positioning and investor confidence.
The most recent analyst rating on (HK:1875) stock is a Buy with a HK$3.00 price target. To see the full list of analyst forecasts on TOT BIOPHARM International Co. Ltd. stock, see the HK:1875 Stock Forecast page.
More about TOT BIOPHARM International Co. Ltd.
Average Trading Volume: 221,382
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.13B
Learn more about 1875 stock on TipRanks’ Stock Analysis page.